Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose oral acetyl-L-carnitine in ischemic stroke
IRCT20150629022965N14Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Acetyl-L-carnitine plus routine stroke treatment with Placebo plus routine stroke treatment (2 arms). Primary endpoints: Serum interleukin-6 level, Serum neuron-specific enolase level and 2 more. Started Mar 2018; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20150629022965N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150629022965N14.